Silence Therapeutics (SLN) Exchange Rate Effect (2024 - 2026)
Silence Therapeutics' (SLN) quarterly Exchange Rate Effect came in at -$17000.0 in Q1 2026, down 107.33% year-on-year from $232000.0 in Q1 2025, and up 86.82% quarter-over-quarter from -$129000.0 in Q4 2025.
Silence Therapeutics (SLN) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Silence Therapeutics has disclosed Exchange Rate Effect across 3 years of filings, most recently posting -$17000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$17000.0, down 107.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$54000.0 (down 116.51% YoY), and the FY2025 annual result was $195000.0, up 225.0% from the prior year.
- Exchange Rate Effect came in at -$17000.0 for Q1 2026 at Silence Therapeutics, up from -$129000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $268000.0 in Q3 2024 to a low of -$159000.0 in Q4 2024.
- The 3-year median for Exchange Rate Effect is -$17000.0 (2026), against an average of $26444.4.
- Peak annual rise in Exchange Rate Effect reached 1514.29% in 2025, while the deepest fall reached 139.55% in 2025.
- Silence Therapeutics' Exchange Rate Effect stood at -$159000.0 in 2024, then grew by 18.87% to -$129000.0 in 2025, then surged by 86.82% to -$17000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$17000.0 (Q1 2026), -$129000.0 (Q4 2025), and -$106000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Silence Therapeutics | 966.41 Mn | 896.33 Mn | 411,000.00 | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -129,000.00 |
| Dec 31, 2025 | -129,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |